GTBIF stock forecast incorporates sector growth drivers like increasing medical cannabis adoption, projected to expand annual industry revenue beyond $30B by 2025, which favors vertically integrated players like Green Thumb. Trading at just 12-times funds from operations (FFO) with a dividend yield approaching 8%, IIPR offers value, income, and cannabis exposure in one stable package. As irrational fears plaguing property owners and pot stocks dissipate, this unique REIT can deliver outsized returns. Wall Street analysts forecast High Tide reaching profitability by fiscal 2025, with rapid earrings growth seen in the years to come. Consensus earnings per share projections call for growth from 9 cents in 2025 to 64 cents in 2030. That implies a forward price-earnings ratio of just 3-times based on 2030 earnings for a company growing at a double-digit clip. Even if High Tide only meets half those profit projections, shares could easily double. Federal legalization will likely hit before 2030 as well, acting as an added catalyst for multiple expansion. GTBIF stock forecast benefits from Green Thumb’s consistent positive cash flow over the past 12 quarters, reducing liquidity risk and supporting expansion into newly legalized states.